XT
SXTC icon

XTX Topco’s China SXT Pharmaceuticals SXTC Stock Holding History

XTX Topco’s Portfolio SXTC Stock Details SXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-152
Closed -$36.4K – 4371
2025
Q4 		$36.4K Buy
+152
New +$32.9K ﹤0.01% 2910

Other funds holding SXTC

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

XTX Topco's SXTC Position: Q1 2026 in Review

XTX Topco sold out of China SXT Pharmaceuticals (SXTC) in Q1 2026, closing a stake of 152 shares — an estimated $36.4K sold.

XTX Topco first reported a position in SXTC in Q4 2025 and held it in 1 quarter. The position peaked at $36.4K in Q4 2025. 4 funds tracked by Wall St. Rank hold SXTC as of Q1 2026.

  • XTX Topco reported no remaining China SXT Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 152 China SXT Pharmaceuticals shares in Q1 2026, an estimated $36.4K.
  • XTX Topco first reported a position in China SXT Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • XTX Topco's China SXT Pharmaceuticals position peaked at $36.4K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held China SXT Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.